Citation Tools
PDFEmerging technologies, pharmacology and therapeutics
Superior weight loss with once-weekly semaglutide versus other glucagon-like peptide-1 receptor agonists is independent of gastrointestinal adverse events
Download to a citation manager
Download the citation for this article by clicking on one of the following citation managers:
- Cite this article as:
- Superior weight loss with once-weekly semaglutide versus other glucagon-like peptide-1 receptor agonists is independent of gastrointestinal adverse events